Beyond Cell Death: New Functions for TNF Family Cytokines in Autoimmunity and Tumor Immunotherapy.
暂无分享,去创建一个
C. Klebanoff | R. Siegel | Fei Yi | N. Frazzette | A. Cruz | Richard M Siegel | Christopher A Klebanoff | Fei Yi | Nicholas Frazzette | Anthony C Cruz | Nick Frazzette
[1] Enric Llorens-Bobadilla,et al. CD95 in cancer: tool or target? , 2013, Trends in molecular medicine.
[2] C. Klebanoff,et al. Silencing stemness in T cell differentiation , 2018, Science.
[3] Daniel Li,et al. CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients. , 2016, The Journal of clinical investigation.
[4] L. Salmena,et al. Requirement for Caspase-8 in NF-κB Activation by Antigen Receptor , 2005, Science.
[5] F. Marincola,et al. Lineage relationship of CD8+ T cell subsets is revealed by progressive changes in the epigenetic landscape , 2015, Cellular and Molecular Immunology.
[6] C. Klebanoff,et al. Sorting Through Subsets: Which T-Cell Populations Mediate Highly Effective Adoptive Immunotherapy? , 2012, Journal of immunotherapy.
[7] C. Klebanoff,et al. Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy. , 2017, JCI insight.
[8] Emad S. Alnemri,et al. A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis , 2001, Nature.
[9] Christian Stemberger,et al. Novel Serial Positive Enrichment Technology Enables Clinical Multiparameter Cell Sorting , 2012, PloS one.
[10] S. Steinberg,et al. Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy , 2011, Clinical Cancer Research.
[11] J. Sundberg,et al. Elimination of antigen-presenting cells and autoreactive T cells by Fas contributes to prevention of autoimmunity. , 2007, Immunity.
[12] Seamus J. Martin,et al. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas , 1995, Nature.
[13] E. Yolcu,et al. Engineering of bone marrow cells with fas-ligand protein-enhances donor-specific tolerance to solid organs. , 2011, Transplantation proceedings.
[14] A. K. Srivastava,et al. Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study. , 2017, The Lancet. Oncology.
[15] S. Ju,et al. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation , 1995, Nature.
[16] Warren Strober,et al. Dominant interfering fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome , 1995, Cell.
[17] I. Sancho-Martinez,et al. Yes and PI3K bind CD95 to signal invasion of glioblastoma. , 2008, Cancer cell.
[18] Mark S. Sundrud,et al. Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics. , 2015, Cancer research.
[19] Guy S. Salvesen,et al. Catalytic activity of the caspase-8-FLIPL complex inhibits RIPK3-dependent necrosis , 2011, Nature.
[20] Junying Yuan,et al. Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis , 1998, Cell.
[21] P. Muranski,et al. Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function. , 2013, The Journal of clinical investigation.
[22] S. Rosenberg,et al. Determinants of Successful CD8+ T-Cell Adoptive Immunotherapy for Large Established Tumors in Mice , 2011, Clinical Cancer Research.
[23] Xiuli Wang,et al. Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy. , 2016, The New England journal of medicine.
[24] M. Croft,et al. Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases , 2017, Nature Reviews Rheumatology.
[25] W I Wood,et al. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. , 1997, Science.
[26] S. Cullen,et al. Fas/CD95-induced chemokines can serve as "find-me" signals for apoptotic cells. , 2013, Molecular cell.
[27] M. Peter,et al. Palmitoylation of CD95 facilitates formation of SDS‐stable receptor aggregates that initiate apoptosis signaling , 2007, The EMBO journal.
[28] Masayuki Fukui,et al. Pathogen-Associated Molecular Patterns Sensitize Macrophages to Fas Ligand-Induced Apoptosis and IL-1β Release1 , 2003, The Journal of Immunology.
[29] F. Marincola,et al. Memory T cell-driven differentiation of naive cells impairs adoptive immunotherapy. , 2015, The Journal of clinical investigation.
[30] M. Peter,et al. CD95 ligand induces motility and invasiveness of apoptosis‐resistant tumor cells , 2004, The EMBO journal.
[31] F. Marincola,et al. Mitochondrial Membrane Potential Identifies Cells with Enhanced Stemness for Cellular Therapy. , 2016, Cell metabolism.
[32] J. Gartner,et al. T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer. , 2016, The New England journal of medicine.
[33] L. Greller,et al. Convergence of TCR and cytokine signaling leads to FOXO3a phosphorylation and drives the survival of CD4+ central memory T cells , 2007, The Journal of experimental medicine.
[34] Seamus J. Martin,et al. Caspase-8 Acts in a Non-enzymatic Role as a Scaffold for Assembly of a Pro-inflammatory "FADDosome" Complex upon TRAIL Stimulation. , 2017, Molecular cell.
[35] G. Stark,et al. NFκB-dependent signaling pathways , 2002 .
[36] L. Hurton,et al. Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells , 2016, Proceedings of the National Academy of Sciences.
[37] S. Yonehara,et al. Fas-Mediated Inflammatory Response in Listeria monocytogenes Infection , 2013, The Journal of Immunology.
[38] B. A. Aksoy,et al. PI3Kδ Inhibition Enhances the Antitumor Fitness of Adoptively Transferred CD8+ T Cells , 2017, Front. Immunol..
[39] H. Kidoya,et al. Involvement of IL-17 in Fas ligand-induced inflammation. , 2004, International immunology.
[40] F. Ramsdell,et al. Fas transduces activation signals in normal human T lymphocytes , 1993, The Journal of experimental medicine.
[41] N. Restifo. Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape , 2000, Nature Medicine.
[42] Atsushi Hase,et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis , 1991, Cell.
[43] M. Essig,et al. Neutralization of CD95 ligand promotes regeneration and functional recovery after spinal cord injury , 2004, Nature Medicine.
[44] S. Rosenberg,et al. Treatment of Patients With Metastatic Cancer Using a Major Histocompatibility Complex Class II-Restricted T-Cell Receptor Targeting the Cancer Germline Antigen MAGE-A3. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[45] L. Salmena,et al. Caspase-8 deficiency in T cells leads to a lethal lymphoinfiltrative immune disorder , 2005, The Journal of experimental medicine.
[46] M. Peter,et al. Resistance of cultured peripheral T cells towards activation‐induced cell death involves a lack of recruitment of FLICE (MACH/caspase 8) to the CD95 death‐inducing signaling complex , 1997, European journal of immunology.
[47] S. Steinberg,et al. Randomized, Prospective Evaluation Comparing Intensity of Lymphodepletion Before Adoptive Transfer of Tumor-Infiltrating Lymphocytes for Patients With Metastatic Melanoma. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[48] S. Ghosh,et al. Crosstalk in NF-κB signaling pathways , 2011, Nature Immunology.
[49] Martin Pule,et al. Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma. , 2011, Blood.
[50] C. Turtle,et al. Generation of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cells. , 2012, Blood.
[51] P. Kiener,et al. Fas (CD95) Induces Proinflammatory Cytokine Responses by Human Monocytes and Monocyte-Derived Macrophages12 , 2003, The Journal of Immunology.
[52] R. Hakem,et al. RIP3 mediates the embryonic lethality of caspase-8-deficient mice , 2011, Nature.
[53] S. Mukai,et al. A novel treatment for ocular tumors using membrane FasL vesicles to activate innate immunity and terminate immune privilege. , 2005, Investigative ophthalmology & visual science.
[54] B. Aggarwal. Signalling pathways of the TNF superfamily: a double-edged sword , 2003, Nature Reviews Immunology.
[55] J. Wigginton,et al. Lack of FasL-mediated killing leads to in vivo tumor promotion in mouse Lewis lung cancer , 2003, Apoptosis.
[56] R. Siegel,et al. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity , 2000, Nature Immunology.
[57] S. Rosenberg,et al. Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer , 2014, Science.
[58] J. Wrangle,et al. β-catenin and PI3Kδ inhibition expands precursor Th17 cells with heightened stemness and antitumor activity. , 2017, JCI insight.
[59] Arnold Munnich,et al. TAB2, TRAF6 and TAK1 are involved in NF-kappaB activation induced by the TNF-receptor, Edar and its adaptator Edaradd. , 2005, Human molecular genetics.
[60] F. Marincola,et al. A human memory T-cell subset with stem cell-like properties , 2011, Nature Medicine.
[61] S. Ju,et al. Fas Ligand Engagement of Resident Peritoneal Macrophages In Vivo Induces Apoptosis and the Production of Neutrophil Chemotactic Factors1 , 2001, The Journal of Immunology.
[62] C. Klebanoff,et al. Paths to stemness: building the ultimate antitumour T cell , 2012, Nature Reviews Cancer.
[63] B. Ksander,et al. Membrane Fas Ligand Activates Innate Immunity and Terminates Ocular Immune Privilege1 , 2002, The Journal of Immunology.
[64] M. Lenardo. lnterleukin-2 programs mouse αβ T lymphocytes for apoptosis , 1991, Nature.
[65] J. Friedberg,et al. Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[66] J. Heath,et al. A kinetic investigation of interacting, stimulated T cells identifies conditions for rapid functional enhancement, minimal phenotype differentiation, and improved adoptive cell transfer tumor eradication , 2018, PloS one.
[67] Sadik H. Kassim,et al. A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response , 2014, Clinical Cancer Research.
[68] D. Lawrence,et al. Molecular Determinants of Kinase Pathway Activation by Apo2 Ligand/Tumor Necrosis Factor-related Apoptosis-inducing Ligand* , 2005, Journal of Biological Chemistry.
[69] T. Waldmann,et al. Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[70] P. Krammer,et al. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95) , 1995, Nature.
[71] S. Nagata,et al. Caspase 1-independent IL-1β release and inflammation induced by the apoptosis inducer Fas ligand , 1998, Nature Medicine.
[72] Yelena L. Pobezinskaya,et al. The role of TRADD in death receptor signaling , 2012, Cell cycle.
[73] H. Blau,et al. Immune response and myoblasts that express Fas ligand. , 1997, Science.
[74] D. Maloney,et al. Accepted Article Preview : Published ahead of advance online publication , 2016 .
[75] R. Levy,et al. Axicabtagene Ciloleucel CAR T‐Cell Therapy in Refractory Large B‐Cell Lymphoma , 2017, The New England journal of medicine.
[76] H. Ford,et al. TRAIL receptor-targeted therapeutics: resistance mechanisms and strategies to avoid them. , 2008, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[77] F. Martinon,et al. The caspase-8 inhibitor FLIP promotes activation of NF-κB and Erk signaling pathways , 2000, Current Biology.
[78] D. Green,et al. FADD and Caspase-8 Mediate Priming and Activation of the Canonical and Noncanonical Nlrp3 Inflammasomes , 2014, The Journal of Immunology.
[79] J. Tschopp,et al. Induction of TNF Receptor I-Mediated Apoptosis via Two Sequential Signaling Complexes , 2003, Cell.
[80] S. Rosenberg,et al. Prospects for gene-engineered T cell immunotherapy for solid cancers , 2016, Nature Medicine.
[81] J. Tschopp,et al. Caspase Activation Is Required for T Cell Proliferation , 1999, The Journal of experimental medicine.
[82] Christine Feig,et al. CD95/Fas promotes tumour growth , 2010, Nature.
[83] P. Muranski,et al. Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells , 2009, Nature Medicine.
[84] J. Pichler,et al. A Phase II, Randomized, Study of Weekly APG101+Reirradiation versus Reirradiation in Progressive Glioblastoma , 2014, Clinical Cancer Research.
[85] G. Nabel,et al. Regulation of the proinflammatory effects of Fas ligand (CD95L). , 1998, Science.
[86] J. Lippincott-Schwartz,et al. Fas/CD95 prevents autoimmunity independently of lipid raft localization and efficient apoptosis induction , 2016, Nature Communications.
[87] D. Green,et al. Cutting Edge: FAS (CD95) Mediates Noncanonical IL-1β and IL-18 Maturation via Caspase-8 in an RIP3-Independent Manner , 2012, The Journal of Immunology.
[88] C. Creighton,et al. Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15. , 2014, Blood.
[89] K. Davis,et al. Tisagenlecleucel in Children and Young Adults with B‐Cell Lymphoblastic Leukemia , 2018, The New England journal of medicine.
[90] B. Howie,et al. Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer , 2017, Science.
[91] E. Simpson,et al. An essential role for Fas ligand in transplantation tolerance induced by donor bone marrow , 1998, Nature Medicine.
[92] Petra Reinke,et al. Comprehensive Approach for Identifying the T Cell Subset Origin of CD3 and CD28 Antibody–Activated Chimeric Antigen Receptor–Modified T Cells , 2017, The Journal of Immunology.
[93] Xuetao Cao,et al. Fas ligation induces IL-1β-dependent maturation and IL-1β-independent survival of dendritic cells: different roles of ERK and NF-κB signaling pathways , 2003 .
[94] J. Goverman,et al. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. , 1994, Science.
[95] R. Siegel,et al. Harnessing programmed cell death as a therapeutic strategy in rheumatic diseases , 2011, Nature Reviews Rheumatology.
[96] Lieping Chen,et al. Molecular mechanisms of T cell co-stimulation and co-inhibition , 2013, Nature Reviews Immunology.
[97] D. Marguet,et al. Palmitoylation is required for efficient Fas cell death signaling , 2007, The EMBO journal.
[98] S. Price,et al. Specific elimination of effector memory CD4+ T cells due to enhanced Fas signaling complex formation and association with lipid raft microdomains , 2011, Cell Death and Differentiation.
[99] T. Speed,et al. Distinct epigenetic signatures delineate transcriptional programs during virus-specific CD8(+) T cell differentiation. , 2014, Immunity.
[100] R. Grossman,et al. HER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial , 2017, JAMA oncology.
[101] T. Gajewski. On the TRAIL toward death receptor-based cancer therapeutics. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[102] S. Srinivasula,et al. Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade , 1997, Cell.
[103] J. Puck,et al. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency , 2002, Nature.
[104] K. Rajewsky,et al. Fas receptor expression in germinal-center B cells is essential for T and B lymphocyte homeostasis. , 2008, Immunity.
[105] Michael Karin,et al. NF-κB: linking inflammation and immunity to cancer development and progression , 2005, Nature Reviews Immunology.
[106] N. Copeland,et al. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis , 1992, Nature.
[107] K. Elkon,et al. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway. , 1999, Journal of immunology.
[108] Elizabeth A. Kruse,et al. Membrane-bound Fas ligand only is essential for Fas-induced apoptosis , 2009, Nature.
[109] S. Grupp,et al. Relation of clinical culture method to T-cell memory status and efficacy in xenograft models of adoptive immunotherapy. , 2014, Cytotherapy.
[110] S. Berger,et al. Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade , 2016, Science.
[111] M. Peter,et al. The CD95(APO-1/Fas) DISC and beyond , 2003, Cell Death and Differentiation.
[112] Peter Scheurich,et al. NFκB activation by Fas is mediated through FADD, caspase-8, and RIP and is inhibited by FLIP , 2004, The Journal of cell biology.